Results 71 to 80 of about 13,581 (183)

Intralesional steroid injection and dilatation for subglottic stenosis in patients with Wegener’s granulomatosis- a review of literature

open access: yesLiaquat Medical Research Journal, 2020
Subglottic stenosis is one of the major complications of the Wegener’s granulomatosis. There are no set guidelines available for management. Intralesional steroid injection and dilatation seems to be a safe and successful method of treatment. We report a
Jawaid Naeem Qureshi
doaj  

Cases of granulomatosis with polyangitis (Wegener's disease) diagnosed in the regional TB dispensary

open access: yesТуберкулез и болезни лёгких, 2020
The article describes 2 cases when granulomatosis with polyangitis (Wegener's disease) were diagnosed in the regional TB dispensary. Publications on the main clinical, radiological and morphological manifestations of granulomatosis with polyangitis were ...
V. V. Tinkova   +4 more
doaj   +1 more source

Demographic and Clinical Insights Into Pyoderma Gangrenosum: A Retrospective Cross‐Sectional Study From a Tertiary Care Hospital

open access: yesHealth Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims Pyoderma gangrenosum (PG) is a rare, non‐infectious inflammatory skin disease often associated with systemic disorders such as inflammatory bowel disease (IBD), malignancies, and autoimmune conditions. This study aimed to investigate the demographic characteristics, comorbidities, differential diagnoses, and treatment ...
Mitra Mirzaei   +3 more
wiley   +1 more source

Immunosuppression and Surgery‐Free Interval in Granulomatosis With Polyangiitis Airway Stenosis

open access: yesThe Laryngoscope, Volume 136, Issue 4, Page 1858-1865, April 2026.
Subglottic and tracheal stenosis are severe manifestations of granulomatosis with polyangiitis (GPA) that often require both endoscopic intervention and systemic immunosuppression. Rituximab may help stabilize GPA‐related airway disease by prolonging the interval between endoscopic procedures and delaying relapse.
Sydney J. Torres   +6 more
wiley   +1 more source

Wegener's granulomatosis

open access: yes, 2009
The immunopathologic disease, Wegener's granulomatosis, presents a challenge to the anesthesiologist due to multisystem involvement resulting in potential abnormalities of the airway, respiratory, circulatory, renal, and central/peripheral nervous ...
Rookard, Paul   +4 more
core   +3 more sources

CTSC Confers Radioresistance in Hepatocellular Carcinoma by Regulating Myeloid‐Derived Suppressor Cells

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 8, April 2026.
ABSTRACT Radiotherapy is an important therapeutic modality for advanced hepatocellular carcinoma (HCC), but the limited understanding of radioresistance mechanisms in HCC has hindered its further clinical development. This work aimed to clarify the essential role of Cathepsin C (CTSC) in regulating radioresistance in HCC.
Jiahuan Xu   +5 more
wiley   +1 more source

Kaposi's sarcoma associated with Wegener’s granulomatosi

open access: yesНаучно-практическая ревматология, 2004
A case of Kaposi's sarcoma development in a pt with Wegener's granulomatosis during immunosupres- sive treatment with cyclophosphane and prednisolone.
T L Zlobina   +5 more
doaj   +1 more source

Rhinologic changes in Wegener's granulomatosis [PDF]

open access: yes, 2002
Twenty-eight patients with a clinical diagnosis of sinonasal Wegener's granulomatosis were referred for imaging during the period 1990-2001. Of these, 10 had clinical symptoms and signs confined to the nose and sinuses and 18 had classical systemic ...
Beale, T, Lloyd, G, Lund, VJ, Howard, D
core  

Wegener's granulomatosis presenting as diffuse pulmonary hemorrhage.

open access: yes, 1991
peer reviewedA 35-year-old woman experienced diffuse intraalveolar haemorrhage with respiratory distress and acute renal failure. Renal histology and evolution confirmed Wegener's granulomatosis.
Glotz, D.   +7 more
core   +1 more source

Therapeutic Dilemmas in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Diffuse Alveolar Hemorrhage and Venous Thromboembolism

open access: yesACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Diffuse alveolar hemorrhage (DAH) is a life‐threatening presentation of antineutrophil cytoplasmic antibody–associated vasculitis (AAV). Patients with AAV are at an increased risk of venous thromboembolic events (VTEs). These manifestations can co‐occur; however, the prognosis and management of these patients are poorly understood. Methods In
Elif D. Ediboglu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy